Cargando…
Delayed Presentation of Acute Generalized Exanthematous Pustulosis Following Treatment with Cefepime in a Patient with COVID-19 without the Use of Hydroxychloroquine
Patient: Male, 78-year-old Final Diagnosis: Acute generalized exanthematous pustulosis (AGEP) Symptoms: Rash Medication:— Clinical Procedure: — Specialty: Allergology • Infectious Diseases OBJECTIVE: Rare disease BACKGROUND: Acute generalized exanthematous pustulosis (AGEP) is a rare exanthem charac...
Autores principales: | Haraszti, Samantha, Sendil, Selin, Jensen, Nichole |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592336/ https://www.ncbi.nlm.nih.gov/pubmed/33097683 http://dx.doi.org/10.12659/AJCR.926901 |
Ejemplares similares
-
Acute Generalized Exanthematous Pustulosis Induced by Cefepime: A Case Report
por: Botelho, L.F.F., et al.
Publicado: (2010) -
Cefepime: Acute generalised exanthematous pustulosis: case report
Publicado: (2020) -
Hydroxychloroquine: Refractory acute generalized exanthematous pustulosis: case report
Publicado: (2021) -
Acute generalized exanthematous pustulosis induced by
hydroxychloroquine: a case with atypical clinical presentation
por: Duman, Hatice, et al.
Publicado: (2017) -
Hydroxychloroquine-induced acute generalized exanthematous pustulosis with positive patch-testing
por: Charfi, Ons, et al.
Publicado: (2015)